Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/14/2010US7851586 Peptides for activation and inhibition of δPKC
12/14/2010US7851510 Gossypol derivatives, production method thereof and uses of same
12/14/2010US7851507 Administering to a lung cancer patient 2-hydroxyoleic acid in an amount effective to inhabit proliferation of the cancer; leukemia, brain metastasis
12/14/2010US7851462 Methods and compositions for inhibiting tumor growth
12/14/2010US7851461 Combination dosage of a cyclooxygenase (COX) inhibitor, a vitamin D3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
12/14/2010US7851437 monoclonal antibody conjugated with peptide drug such as dolastatin derivative
12/14/2010US7851181 Generating monoclonal antibodies specific to insulin-like growth factor receptor-I (IGFR1) for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7851168 Using 7a5/prognostin expresion profile to diagnose/prognose colon cancer
12/14/2010US7850993 Drug-releasing system of biodegradable polymer type
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850966 Method of treating breast cancer using anti-HER2 antibody variants
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010US7850961 Mammary gland tumor cell for use as model in screening cell proliferative disorders
12/14/2010US7850956 Immunization by inoculation of DNA transcription unit
12/14/2010CA2715662A1 Phenylpropanoid diglycerides for the treatment of cancer
12/14/2010CA2561374C Process for producing folic acid derivatives
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2485424C Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2462376C Liposome loading with metal ions
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2347100C Novel indenoisoquinolines as antineoplastic agents
12/14/2010CA2308116C Low-toxicity human interferon-alpha analog
12/14/2010CA2233316C Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
12/09/2010WO2010141956A2 Methods and compositions for the treatment of cancer
12/09/2010WO2010141842A2 Interlaced method for treating cancer or a precancerous condition
12/09/2010WO2010141809A1 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141771A1 Nucleic acid modulators of glycoprotein vi
12/09/2010WO2010141761A2 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010WO2010141680A2 Hedgehog pathway antagonists and methods of use
12/09/2010WO2010141630A1 Compositions and methods for treatment of cancer by disrupting the lh/lhr signaling pathway
12/09/2010WO2010141406A2 Amino pyrimidine anticancer compounds
12/09/2010WO2010141143A2 Engineered avirulent bacteria strains and use in medical treatments
12/09/2010WO2010141093A2 Co-signaling methods for treating cancers
12/09/2010WO2010141024A1 Prostate immobilizer apparatus
12/09/2010WO2010140834A2 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof
12/09/2010WO2010140727A1 The composition for the treatment of cancers and inhibition of metastasis containing extracts and fractions of the mangolia obovata
12/09/2010WO2010140694A1 Method for screening of inhibitor using factor capable of enhancing production of amyloid-beta peptide, and inhibitor obtained by same
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010140409A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
12/09/2010WO2010140154A1 Proteins modified with (amino)-monosaccharide-biotin adduct
12/09/2010WO2010139982A1 Indole derivatives for the stimulation of stem cell proliferation
12/09/2010WO2010139981A2 Processes for preparing crystalline forms
12/09/2010WO2010139980A1 Process for preparing crystalline dasatinib monohydrate
12/09/2010WO2010139979A2 Processes for preparing crystalline forms
12/09/2010WO2010139966A1 Azole derivatives as wtn pathway inhibitors
12/09/2010WO2010139942A2 Nanoparticle for biomolecule delivery
12/09/2010WO2010139784A1 Lysine-specific demethylase 1 (lsd1) is a biomarker for breast cancer
12/09/2010WO2010139747A1 1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES
12/09/2010WO2010139741A1 Fgf-21 for treating cancers
12/09/2010WO2010139731A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
12/09/2010WO2010139678A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms
12/09/2010WO2010139665A1 Treatment of malignant diseases
12/09/2010WO2010139469A2 Antibodies against human ccn1 and uses thereof
12/09/2010WO2010139401A1 Method for cancer therapy based on co-administration of a parvovirus and a cytokine
12/09/2010WO2010139288A1 5,7-disubstituted 3-isopropylpyrazolo[4,3-d]pyrimidines for use as medicaments and pharmaceutical compositions
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010WO2010139090A1 N-phenyl dichloroacetamide and their derivatives, preparation methods and uses theirof
12/09/2010WO2010139069A1 Small molecule inhibitors of polynucleotide kinase/phosphatase. poly(adp-ribose) polymerase and uses thereof
12/09/2010WO2010139026A1 Therapeutic and diagnostic molecules
12/09/2010WO2010115836A4 Substituted piperidines as ccr3 antagonists
12/09/2010WO2010100060A3 Method for increasing endogenous plasmalogen levels in mammals
12/09/2010WO2010091386A3 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/09/2010WO2009142525A3 Capsulating system binding to nucleolin
12/09/2010WO2009130469A8 Dna-pk inhibitors
12/09/2010US20100312328 Drug-delivery endovascular stent and method of forming the same
12/09/2010US20100312312 Method for selective photodynamic therapy and light source for implementation thereof
12/09/2010US20100311838 Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
12/09/2010US20100311826 Cytotoxic xanthone compounds
12/09/2010US20100311825 Novel taxoid-based compositions
12/09/2010US20100311820 Nucleic acid modulators of glycoprotein vi
12/09/2010US20100311815 Mir-101 cancer markers
12/09/2010US20100311814 Modulation of stat5 expression
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311808 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES
12/09/2010US20100311805 Combination of histone deacetylase inhibitors and radiation
12/09/2010US20100311804 Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
12/09/2010US20100311799 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010US20100311796 method for the separation and purification of epothilones
12/09/2010US20100311794 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/09/2010US20100311787 Compounds for inflammation and immune-related uses
12/09/2010US20100311784 Stereoselective process and crystalline forms of a camptothecin
12/09/2010US20100311783 Stereoselective process and crystalline forms of a camptothecin
12/09/2010US20100311779 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311774 Combination Comprising Paclitaxel for Treating Ovarian Cancer
12/09/2010US20100311772 Method and compounds for inhibition of cell death
12/09/2010US20100311768 Use of purine derivatives for the manufacture of a medicament
12/09/2010US20100311765 Metabolic degradation inhibitors for anti-hyperproliferative agents
12/09/2010US20100311764 Methods of using 4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds
12/09/2010US20100311762 Reduction of toxicity of multi-targeting antifolates
12/09/2010US20100311757 Salarins And Tulearins, Compositions And Uses Thereof
12/09/2010US20100311751 Solid dispersions containing an apoptosis-promoting agent
12/09/2010US20100311748 Heterocyclic amides useful for the treatment of cancer and psoriasis
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
1 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 ... 2211